Global Cord Blood Co. (NYSE:CO - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.03 and traded as high as $1.50. Global Cord Blood shares last traded at $1.50, with a volume of 9,896 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen began coverage on Global Cord Blood in a research report on Saturday, May 17th. They issued a "strong-buy" rating on the stock.
Read Our Latest Stock Report on Global Cord Blood
Global Cord Blood Stock Performance
The company has a market capitalization of $182.33 million, a PE ratio of 2.34 and a beta of 0.16. The company's 50-day moving average is $1.04 and its 200 day moving average is $1.03.
About Global Cord Blood
(
Get Free Report)
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.
Further Reading
Before you consider Global Cord Blood, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Cord Blood wasn't on the list.
While Global Cord Blood currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
